株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の子宮頸癌診断検査市場

Global Cervical Cancer Diagnostic Tests Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 321448
出版日 ページ情報 英文 103 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
世界の子宮頸癌診断検査市場 Global Cervical Cancer Diagnostic Tests Market 2014-2018
出版日: 2014年12月17日 ページ情報: 英文 103 Pages
概要

子宮頸癌診断検査は女性の子宮頸部の前癌病変または癌病変の存在を特定するために用いられます。初期の細胞診とHPV検査で陽性がでると、診断確定のために膣鏡診や生検が行なわれ、その結果陽性の場合、さらに画像検査によって癌の悪性度合いを決定します。世界の子宮頸癌診断検査市場は2013〜2018年にCAGR10.89%で拡大するとみられています。

当レポートでは、世界の子宮頸癌診断検査市場の現状と今後の見通し、市場規模、セグメント別の売上動向、地域別動向、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語解説

第3章 当レポートの範囲

第4章 市場調査方法

第5章 イントロダクション

第6章 疾患パラダイム

  • 疫学
  • 子宮頸癌の原因
  • 子宮頸癌の診断

第7章 市場環境

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第8章 検査別市場セグメンテーション

  • 細胞診
  • HPV検査
  • 膣鏡診
  • 子宮頸癌生検
  • 検査別市場セグメンテーション
  • 世界のHPV検査市場
  • 世界の膣鏡診市場
  • 世界の細胞診市場
  • 世界の子宮頸癌生検市場

第9章 技術別市場セグメンテーション

第10章 手法別市場セグメンテーション

第11章 地域別セグメンテーション

  • 地域別セグメンテーション
  • 南北アメリカ
  • EMEA
  • アジア太平洋地域

第12章 購買基準

第13章 市場成長促進因子

第14章 促進因子とその影響

第15章 市場の課題

第16章 市場促進因子と課題の影響

第17章 市場動向

第18章 動向とその影響

第19章 ベンダー環境

  • 競合シナリオ
  • 市場シェア分析
  • その他の注目すべきベンダー

第20章 主要ベンダー分析

  • Abbott Laboratories
  • Becton, Dickinson and Co.
  • Hologic Inc.
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

第21章 当シリーズの他のレポート

図表

目次
Product Code: IRTNTR4839

About Cervical Cancer Diagnostic Tests

Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer.

TechNavio's analysts forecast the Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.89 percent over the period 2013-2018.

Covered in this Report

The report covers the present scenario and the growth prospects of the Global Cervical Cancer Diagnostic Tests market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer:

  • Pap Smear Test
  • HPV Testing
  • Colposcopy
  • Biopsy

In addition, the report includes the type of method used to identify cervical cancer:

  • Molecular method
  • Cytopathological method
  • Physical method

Technological types used in cervical cancer identification are also discussed in this report:

  • ELISA
  • FISH
  • NASBA
  • PCR
  • Staining & Microscopy
  • Optical Imaging

TechNavio's report, the Global Cervical Cancer Diagnostic Tests Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cervical Cancer Diagnostic Tests market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Becton Dickinson
  • Hologic
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

Other Prominent Vendors

  • Anthera Pharmaceuticals
  • Arbor Vita
  • Autogenomics
  • Biolight Meditech
  • BioMerieux
  • Biovantra
  • Cancer Genetics
  • Cervia Diagnostics
  • Centrel
  • Cooper Surgical
  • Cytoimmun
  • DySIS Medical
  • Edan
  • Femasys
  • Greiner Bio One
  • Guided Therapeutics
  • Incell dx
  • Innogenetics
  • Kernel Medical
  • Lutech Industries
  • Medgyn
  • Micromedic Technologies
  • Norchip
  • Olympus Medical
  • OncoHealth Corp
  • Optomic
  • Optopol Technology
  • Shenzhen Goldcare Meditech
  • Sunray
  • Zilico

Market Driver

  • Increased Incidence of Smoking
  • For a full, detailed list, view our report

Market Challenge

  • Lack of Awareness
  • For a full, detailed list, view our report

Market Trend

  • Development of New Diagnostic Platforms
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Disease Paradigm

  • 06.1. Epidemiology
  • 06.2. Causes of Cervical Cancer
  • 06.3. Diagnosis of Cervical Cancer

07. Market Landscape

  • 07.1. Market Overview
  • 07.2. Market Size and Forecast
  • 07.3. Five Forces Analysis

08. Market Segmentation by Type of Test

  • 08.1. Pap Smear Test
    • 08.1.1. Conventional Pap
    • 08.1.2. Liquid-based cytology
  • 08.2. HPV Testing
  • 08.3. Colposcopy
  • 08.4. Cervical Cancer Biopsy
    • 08.4.1. LEEP
    • 08.4.2. ECC
    • 08.4.3. Cone Biopsy
  • 08.5. Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
  • 08.6. Global HPV Testing Market
    • 08.6.1. Market Size and Forecast
  • 08.7. Global Colposcopy Market
    • 08.7.1. Market Size and Forecast
  • 08.8. Global Pap Smear Test Market
    • 08.8.1. Market Size and Forecast
  • 08.9. Global Cervical Cancer Biopsy Market
    • 08.9.1. Market Size and Forecast

09. Market Segmentation by Technology

  • 09.1. ELISA
  • 09.2. FISH
  • 09.3. NASBA
  • 09.4. PCR
  • 09.5. Multichromatic Staining and Microscopy
  • 09.6. Optical Imaging

10. Market Segmentation by Method

  • 10.1. Molecular Method
  • 10.2. Cytopathological Method
  • 10.3. Physical Method

11. Geographical Segmentation

  • 11.1. Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market
  • 11.2. Cervical Cancer Diagnostic Tests Market in Americas
    • 11.2.1. Market Size and Forecast
  • 11.3. Cervical Cancer Diagnostic Tests Market in EMEA Region
    • 11.3.1. Market Size and Forecast
  • 11.4. Cervical Cancer Diagnostic Tests Market in APAC Region
    • 11.4.1. Market Size and Forecast

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

  • 19.1. Competitive Scenario
    • 19.1.1. Key News
    • 19.1.2. Mergers and Acquisitions
  • 19.2. Market Share Analysis 2013
  • 19.3. Other Prominent Vendors

20. Key Vendor Analysis

  • 20.1. Abbott Laboratories
    • 20.1.1. Key Facts
    • 20.1.2. Business Overview
    • 20.1.3. Business Segmentation by Revenue
    • 20.1.4. Business Segmentation by Revenue 2011 and 2012
    • 20.1.5. Geographical Segmentation by Revenue
    • 20.1.6. Business Strategy
    • 20.1.7. Key Information
    • 20.1.8. SWOT Analysis
  • 20.2. Becton, Dickinson and Co.
    • 20.2.1. Key Facts
    • 20.2.2. Business Description
    • 20.2.3. Business Segmentation
    • 20.2.4. Revenue Segmentation by Business
    • 20.2.5. Segmental Revenue Comparison - 2013 and 2012
    • 20.2.6. Revenue Segmentation by Geography
    • 20.2.7. Business Strategy
    • 20.2.8. Key Developments
    • 20.2.9. SWOT Analysis
  • 20.3. Hologic Inc.
    • 20.3.1. Key Facts
    • 20.3.2. Business Overview
    • 20.3.3. Business Segmentation by Revenue 2013
    • 20.3.4. Business Segmentation by Revenue 2012 and 2013
    • 20.3.5. Sales by Geography
    • 20.3.6. Business Strategy
    • 20.3.7. Key Developments
    • 20.3.8. SWOT Analysis
  • 20.4. Qiagen
    • 20.4.1. Key Facts
    • 20.4.2. Business Overview
    • 20.4.3. Product Segmentation by Revenue 2013
    • 20.4.4. Product Segmentation by Revenue 2012 and 2013
    • 20.4.5. Geographical Segmentation by Revenue 2013
    • 20.4.6. Business Strategy
    • 20.4.7. Recent Developments
    • 20.4.8. SWOT Analysis
  • 20.5. Quest Diagnostics
    • 20.5.1. Key Facts
    • 20.5.2. Business Overview
    • 20.5.3. Business Segmentation by Revenue 2013
    • 20.5.4. Business Segmentation by Revenue 2011-2013
    • 20.5.5. Geographical Segmentation by Revenue 2013
    • 20.5.6. Business Strategy
    • 20.5.7. Recent Developments
    • 20.5.8. SWOT Analysis
  • 20.6. Roche Diagnostics
    • 20.6.1. Key Facts
    • 20.6.2. Business Overview
    • 20.6.3. Business Segmentation by Revenue 2013
    • 20.6.4. Geographical Segmentation by Revenue 2013
    • 20.6.5. Business Strategy
    • 20.6.6. Recent Developments

21. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Incidence of Cervical Cancer (2013-2018)
  • Exhibit 3: Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
  • Exhibit 4: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test
  • Exhibit 5: Segmentation of Cervical Cancer Diagnostic Test Products by Type of Test
  • Exhibit 6: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018 (US$ million)
  • Exhibit 7: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Type of Test 2013-2018
  • Exhibit 8: Global HPV Testing Market 2013-2018 (US$ million)
  • Exhibit 9: Global Colposcopy Market 2013-2018 (US$ million)
  • Exhibit 10: Global Pap Smear Test Market 2013-2018 (US$ million)
  • Exhibit 11: Global Cervical Cancer Biopsy Market 2013-2018 (US$ million)
  • Exhibit 12: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Technology
  • Exhibit 13: Cervical Cancer Diagnostic Test Products Segmented by Technology
  • Exhibit 14: Segmentation of Global Cervical Cancer Diagnostic Tests Market by Method
  • Exhibit 15: List of Tests Segmented Based on Methods used in Cervical Cancer Diagnostic Tests
  • Exhibit 16: Geographical Segmentation of Global Cervical Cancer Diagnostic Tests Market 2013-2018 (US$ million)
  • Exhibit 17: Global Cervical Cancer Diagnostic Tests Market by Geographical Segmentation 2013-2018
  • Exhibit 18: Cervical Cancer Diagnostic Tests Market in Americas 2013-2018 (US$ million)
  • Exhibit 19: Cervical Cancer Diagnostic Tests Market in EMEA Region 2013-2018 (US$ million)
  • Exhibit 20: Cervical Cancer Diagnostic Tests Market in APAC Region 2013-2018 (US$ million)
  • Exhibit 21: Advantages and Limitations of Various Diagnostic Platforms
  • Exhibit 22: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 23: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 24: Product Categorization of Becton, Dickinson and Co.
  • Exhibit 25: Revenue Segmentation of Becton, Dickinson and Co. 2013
  • Exhibit 26: Revenue Comparison (US$ million)
  • Exhibit 27: Revenue Segmentation of Becton, Dickinson and Co. by Geography 2013
  • Exhibit 28: Revenue Segmentation of Hologic Inc. 2013
  • Exhibit 29: Revenue Comparison FY2012 and FY2013 (US$ million)
  • Exhibit 30: Hologic Inc.: Sales by Geography 2013
  • Exhibit 31: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 32: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 33: Qiagen: Geographical Segmentation by Revenue 2013
  • Exhibit 34: Quest Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 35: Quest Diagnostics: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 36: Quest Diagnostics: Geographical Segmentation by Revenue 2013
  • Exhibit 37: Roche Diagnostics: Business Segmentation by Revenue 2013
  • Exhibit 38: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Back to Top